Signaling by CSF3 (G-CSF)
Xing Y, Zhao MF. Colony Stimulating Factor 3 Mutations and Myeloid Malignancies. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):103–7. doi: 10.3881/j.issn.1000-503x.2016.01.019. PMID: 26956865.; Bunda S, Burrell K, Heir P, Zeng L, Alamsahebpour A, Kano Y, Raught B, Zhang Z, Zadeh G, Ohh M. Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis. Nature Communications. 2015 Nov 30;6(1):8859. doi: 10.1038/ncomms9859.; Futosi K, Fodor S, Mócsai A. Neutrophil cell surface receptors and their intracellular signal transduction pathways. International Immunopharmacology. 2013 Nov;17(3):638–50. doi: 10.1016/j.intimp.2013.06.034.; Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney SK, Tognon CE, Pond JB, Collins RH, Goueli B, Oh ST, Deininger MW, Chang BH, Loriaux MM, Druker BJ, Tyner JW. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013 May 09;368(19):1781–90. PMID: 23656643; PMCID: PMC3730275.; Vandenberghe P, Beel K. Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS. Pediatr Rep. 2011 Jun 22;3 Suppl 2():e9. PMID: 22053285; PMCID: PMC3206537.; Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood. 2010 Jun 24;115(25):5131–6. doi: 10.1182/blood-2010-01-234120. PMID: 20237318.; Panopoulos AD, Watowich SS: Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine. 2008 Jun;42(3):277-88. doi: 10.1016/j.cyto.2008.03.002. Epub 2008 Apr 8.; Kendrick TS, Bogoyevitch MA. Activation of mitogen-activated protein kinase pathways by the granulocyte colony-stimulating factor receptor: mechanisms and functional consequences. Front Biosci. 2007 Jan 01;12():591–607. doi: 10.2741/2085. PMID: 17127320.; Touw IP, van de Geijn GJ. Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front Biosci. 2007 Jan 01;12():800–15. doi: 10.2741/2103. PMID: 17127321.; Ward AC. The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease. Front Biosci. 2007 Jan 01;12():608–18. doi: 10.2741/2086. PMID: 17127322.; Sampson M, Zhu QS, Corey SJ. Src kinases in G-CSF receptor signaling. Front Biosci. 2007 Jan 01;12():1463–74. doi: 10.2741/2160. PMID: 17127394.; Zeidler C. Congenital neutropenias. Hematology. 2005;10 Suppl 1():306–11. doi: 10.1080/10245330512331389944. PMID: 16188692.; Roberts AW. G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors. 2005 Mar;23(1):33–41. doi: 10.1080/08977190500055836. PMID: 16019425.; Basu S, Dunn A, Ward A. G-CSF: function and modes of action (Review). Int J Mol Med. 2002 Jul 01;(). doi: 10.3892/ijmm.10.1.3.; Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol. 2002 Apr;39(2):82–8. doi: 10.1053/shem.2002.31913. PMID: 11957189.; Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995 Aug 24;333(8):487–93. doi: 10.1056/nejm199508243330804. PMID: 7542747.; Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ. Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc. Natl. Acad. Sci. U.S.A. 1994 May 24;91(11):4683–7. doi: 10.1073/pnas.91.11.4683.; Nicholson SE, Oates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton JE. Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. U.S.A. 1994 Apr 12;91(8):2985–8. doi: 10.1073/pnas.91.8.2985.